{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:19:36Z","timestamp":1792621176224,"version":"4.5.0"},"reference-count":65,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2011,7,22]],"date-time":"2011-07-22T00:00:00Z","timestamp":1311292800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0021954","type":"journal-article","created":{"date-parts":[[2011,7,22]],"date-time":"2011-07-22T18:53:26Z","timestamp":1311360806000},"page":"e21954","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":58,"title":["Rivastigmine Lowers A\u03b2 and Increases sAPP\u03b1 Levels, Which Parallel Elevated Synaptic Markers and Metabolic Activity in Degenerating Primary Rat Neurons"],"prefix":"10.1371","volume":"6","author":[{"given":"Jason A.","family":"Bailey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balmiki","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel H.","family":"Greig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debomoy K.","family":"Lahiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,7,22]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jalz.2011.02.004","article-title":"2011 Alzheimer's disease facts and figures.","volume":"7","author":"W Thies","year":"2011","journal-title":"Alzheimers Dement"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/archneur.60.8.1119","article-title":"Alzheimer disease in the US population: prevalence estimates using the 2000 census.","volume":"60","author":"LE Hebert","year":"2003","journal-title":"Arch Neurol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/mp.2009.82","article-title":"The LEARn model: an epigenetic explanation for idiopathic neurobiological diseases.","volume":"14","author":"DK Lahiri","year":"2009","journal-title":"Mol Psychiatry"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.exger.2010.01.001","article-title":"The \u201cLEARn\u201d (Latent Early-life Associated Regulation) model integrates environmental risk factors and the developmental basis of Alzheimer's disease, and proposes remedial steps.","volume":"45","author":"DK Lahiri","year":"2010","journal-title":"Exp Gerontol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1001\/jama.2009.1144","article-title":"Physical activity, diet, and risk of Alzheimer disease.","volume":"302","author":"N Scarmeas","year":"2009","journal-title":"JAMA"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1002\/gps.2043","article-title":"Risk-reducing effect of education in Alzheimer's disease.","volume":"23","author":"SB Sando","year":"2008","journal-title":"Int J Geriatr Psychiatry"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1523\/JNEUROSCI.4405-07.2008","article-title":"Alzheimer's disease (AD)-like pathology in aged monkeys after infantile exposure to environmental metal lead (Pb): evidence for a developmental origin and environmental link for AD.","volume":"28","author":"J Wu","year":"2008","journal-title":"J Neurosci"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1177\/070674370404900203","article-title":"Alzheimer's disease, genes, and environment: the value of international studies.","volume":"49","author":"HC Hendrie","year":"2004","journal-title":"Can J Psychiatry"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1001\/archgenpsychiatry.2009.208","article-title":"Effect of a purpose in life on risk of incident Alzheimer disease and mild cognitive impairment in community-dwelling older persons.","volume":"67","author":"PA Boyle","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.","volume":"297","author":"J Hardy","year":"2002","journal-title":"Science"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2174\/1389450033346957","article-title":"A critical analysis of new molecular targets and strategies for drug developments in Alzheimer's disease.","volume":"4","author":"DK Lahiri","year":"2003","journal-title":"Curr Drug Targets"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.coph.2009.06.012","article-title":"Neuroinflammation in Alzheimer's disease: different molecular targets and potential therapeutic agents including curcumin.","volume":"9","author":"B Ray","year":"2009","journal-title":"Curr Opin Pharmacol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.cbi.2009.11.018","article-title":"Cholinesterase inhibitors and memory.","volume":"187","author":"G Pepeu","year":"2010","journal-title":"Chem Biol Interact"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"86","DOI":"10.2174\/156720509787602861","article-title":"Cholinesterase inhibitors and beyond.","volume":"6","author":"G Pepeu","year":"2009","journal-title":"Curr Alzheimer Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0006-8993(93)90464-X","article-title":"NMDA receptor-mediated glutamate toxicity of cultured cerebellar, cortical and mesencephalic neurons: neuroprotective properties of amantadine and memantine.","volume":"613","author":"M Weller","year":"1993","journal-title":"Brain Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/jnr.22172","article-title":"Memantine lowers amyloid-beta peptide levels in neuronal cultures and in APP\/PS1 transgenic mice.","volume":"88","author":"GM Alley","year":"2010","journal-title":"J Neurosci Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.bbrc.2010.12.053","article-title":"MicroRNA-101 downregulates Alzheimer's amyloid-beta precursor protein levels in human cell cultures and is differentially expressed.","volume":"404","author":"JM Long","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1385\/NMM:1:1:1","article-title":"Advances in the cellular and molecular biology of the beta-amyloid protein in Alzheimer's disease.","volume":"1","author":"K Sambamurti","year":"2002","journal-title":"Neuromolecular Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1749-6632.1996.tb34433.x","article-title":"APP gene family. Alternative splicing generates functionally related isoforms.","volume":"777","author":"R Sandbrink","year":"1996","journal-title":"Ann N Y Acad Sci"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0169-328X(97)00045-4","article-title":"Cell-specific expression of beta-amyloid precursor protein isoform mRNAs and proteins in neurons and astrocytes.","volume":"47","author":"HA Rohan de Silva","year":"1997","journal-title":"Brain Res Mol Brain Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.neuint.2004.08.006","article-title":"Amyloid-beta deposition in the cerebral cortex in Dementia with Lewy bodies is accompanied by a relative increase in AbetaPP mRNA isoforms containing the Kunitz protease inhibitor.","volume":"46","author":"M Barrachina","year":"2005","journal-title":"Neurochem Int"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"29615","DOI":"10.1074\/jbc.R800019200","article-title":"Amyloid precursor protein trafficking, processing, and function.","volume":"283","author":"G Thinakaran","year":"2008","journal-title":"J Biol Chem"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1152\/physrev.1997.77.4.1081","article-title":"Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives.","volume":"77","author":"MP Mattson","year":"1997","journal-title":"Physiol Rev"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0301-0082(03)00089-3","article-title":"Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory.","volume":"70","author":"PR Turner","year":"2003","journal-title":"Prog Neurobiol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1523\/JNEUROSCI.0861-04.2004","article-title":"A seed for Alzheimer amyloid in the brain.","volume":"24","author":"H Hayashi","year":"2004","journal-title":"J Neurosci"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2174\/156802606776743066","article-title":"The role of amyloid-beta derived diffusible ligands (ADDLs) in Alzheimer's disease.","volume":"6","author":"SM Catalano","year":"2006","journal-title":"Curr Top Med Chem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jneumeth.2008.08.001","article-title":"Abeta(1\u201342) reduces synapse number and inhibits neurite outgrowth in primary cortical and hippocampal neurons: a quantitative analysis.","volume":"175","author":"NA Evans","year":"2008","journal-title":"J Neurosci Methods"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ana.410300410","article-title":"Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment.","volume":"30","author":"RD Terry","year":"1991","journal-title":"Ann Neurol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.neurobiolaging.2005.09.012","article-title":"Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment.","volume":"27","author":"SW Scheff","year":"2006","journal-title":"Neurobiol Aging"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"15016","DOI":"10.1074\/jbc.M808755200","article-title":"Neuroprotective secreted amyloid precursor protein acts by disrupting amyloid precursor protein dimers.","volume":"284","author":"M Gralle","year":"2009","journal-title":"J Biol Chem"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1471-4159.2009.06490.x","article-title":"A novel effect of rivastigmine on pre-synaptic proteins and neuronal viability in a neurodegeneration model of fetal rat primary cortical cultures and its implication in Alzheimer's disease.","volume":"112","author":"JA Bailey","year":"2010","journal-title":"J Neurochem"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1517\/14656566.2.4.653","article-title":"Review of rivastigmine and its clinical applications in Alzheimer's disease and related disorders.","volume":"2","author":"A Desai","year":"2001","journal-title":"Expert Opin Pharmacother"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.mcn.2010.04.007","article-title":"sAPPalpha antagonizes dendritic degeneration and neuron death triggered by proteasomal stress.","volume":"44","author":"E Copanaki","year":"2010","journal-title":"Mol Cell Neurosci"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/jnr.490350513","article-title":"Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination.","volume":"35","author":"GJ Brewer","year":"1993","journal-title":"J Neurosci Res"},{"key":"ref35","first-page":"67","article-title":"Pharmaceutical Biotechnology (3rd Ed.).","author":"DJA Crommelin","year":"2007"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.neuroscience.2011.03.067","article-title":"Restraint stress and repeated corticotrophin-releasing factor receptor activation in the amygdala both increase amyloid-beta precursor protein and amyloid-beta peptide but have divergent effects on brain-derived neurotrophic factor and pre-synaptic proteins in the prefrontal cortex of rats.","volume":"184","author":"B Ray","year":"2011","journal-title":"Neuroscience"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1124\/jpet.106.112102","article-title":"The experimental Alzheimer's disease drug posiphen [(+)-phenserine] lowers amyloid-beta peptide levels in cell culture and mice.","volume":"320","author":"DK Lahiri","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"ref38","first-page":"36","article-title":"Image Processing with ImageJ.","volume":"11","author":"MD Abramoff","year":"2004","journal-title":"Biophotonics International"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.bbrc.2010.12.053","article-title":"MicroRNA-101 downregulates Alzheimer's amyloid-beta precursor protein levels in human cell cultures and is differentially expressed.","volume":"404","author":"JM Long","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1471-4159.2010.07145.x","article-title":"Oxidative insults to neurons and synapse are prevented by aged garlic extract and S-allyl-L-cysteine treatment in the neuronal culture and APP-Tg mouse model.","volume":"117","author":"B Ray","year":"2011","journal-title":"J Neurochem"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/ana.21051","article-title":"Orally available compound prevents deficits in memory caused by the Alzheimer amyloid-beta oligomers.","volume":"60","author":"M Townsend","year":"2006","journal-title":"Ann Neurol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1749-6632.1997.tb48495.x","article-title":"Effects of cholinesterase inhibitors on the secretion of beta-amyloid precursor protein in cell cultures.","volume":"826","author":"DK Lahiri","year":"1997","journal-title":"Ann N Y Acad Sci"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/jnr.490370612","article-title":"Tacrine alters the secretion of the beta-amyloid precursor protein in cell lines.","volume":"37","author":"DK Lahiri","year":"1994","journal-title":"J Neurosci Res"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1749-6632.1996.tb32603.x","article-title":"Apolipoprotein E genotype and gender influence response to tacrine therapy.","volume":"802","author":"MR Farlow","year":"1996","journal-title":"Ann N Y Acad Sci"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF02736847","article-title":"Differential effect of tacrine and physostigmine on the secretion of the beta-amyloid precursor protein in cell lines.","volume":"7","author":"DK Lahiri","year":"1996","journal-title":"J Mol Neurosci"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF02685889","article-title":"Differential effects of two hexahydropyrroloindole carbamate-based anticholinesterase drugs on the amyloid beta protein pathway involved in Alzheimer's disease.","volume":"9","author":"DK Lahiri","year":"2007","journal-title":"Neuromolecular Med"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"7605","DOI":"10.1073\/pnas.131152998","article-title":"Phenserine regulates translation of beta -amyloid precursor protein mRNA by a putative interleukin-1 responsive element, a target for drug development.","volume":"98","author":"KT Shaw","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/jnr.490350513","article-title":"Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination.","volume":"35","author":"GJ Brewer","year":"1993","journal-title":"J Neurosci Res"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0169-328X(97)00045-4","article-title":"Cell-specific expression of beta-amyloid precursor protein isoform mRNAs and proteins in neurons and astrocytes.","volume":"47","author":"HA Rohan de Silva","year":"1997","journal-title":"Brain Res Mol Brain Res"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.brainres.2007.05.050","article-title":"Expression of APP pathway mRNAs and proteins in Alzheimer's disease.","volume":"1161","author":"T Matsui","year":"2007","journal-title":"Brain Res"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s007020050070","article-title":"The effects of excitotoxicity on the expression of the amyloid precursor protein gene in the brain and its modulation by neuroprotective agents.","volume":"105","author":"PK Panegyres","year":"1998","journal-title":"J Neural Transm"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1046\/j.1471-4159.1996.67051882.x","article-title":"Increased activity-regulating and neuroprotective efficacy of alpha-secretase-derived secreted amyloid precursor protein conferred by a C-terminal heparin-binding domain.","volume":"67","author":"K Furukawa","year":"1996","journal-title":"J Neurochem"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1023\/A:1015131516649","article-title":"Molecular basis of neuroprotective activities of rasagiline and the anti-Alzheimer drug TV3326 [(N-propargyl-(3R)aminoindan-5-YL)-ethyl methyl carbamate].","volume":"21","author":"MB Youdim","year":"2001","journal-title":"Cell Mol Neurobiol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1096\/fj.02-0198fje","article-title":"Involvement of MAP kinase in the regulation of amyloid precursor protein processing by novel cholinesterase inhibitors derived from rasagiline.","volume":"16","author":"M Yogev-Falach","year":"2002","journal-title":"FASEB J"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1749-6632.2001.tb03622.x","article-title":"Neuroprotective effects of novel cholinesterase inhibitors derived from rasagiline as potential anti-Alzheimer drugs.","volume":"939","author":"M Weinstock","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1471-4159.2009.06116.x","article-title":"Regulation of exocytotic protein expression and Ca2+-dependent peptide secretion in astrocytes.","volume":"110","author":"S Paco","year":"2009","journal-title":"J Neurochem"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3233\/JAD-2010-100090","article-title":"Reduction in post-synaptic scaffolding PSD-95 and SAP-102 protein levels in the Alzheimer inferior temporal cortex is correlated with disease pathology.","volume":"21","author":"DT Proctor","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/00005072-199708000-00011","article-title":"Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease.","volume":"56","author":"CI Sze","year":"1997","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00702-005-0312-6","article-title":"Longitudinal PET evaluation of cerebral glucose metabolism in rivastigmine treated patients with mild Alzheimer's disease.","volume":"113","author":"E Stefanova","year":"2006","journal-title":"J Neural Transm"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s00213-007-0725-z","article-title":"Changes in brain 11C-nicotine binding sites in patients with mild Alzheimer's disease following rivastigmine treatment as assessed by PET.","volume":"191","author":"A Kadir","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0014-2999(99)00643-3","article-title":"Effect of rivastigmine on scopolamine-induced memory impairment in rats.","volume":"383","author":"C Bejar","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1007\/s00702-009-0297-7","article-title":"Peripheral cholinoceptor antagonist anisodamine counteracts cholinergic adverse effects and facilitates cognitive amelioration of rivastigmine.","volume":"116","author":"WW Zhang","year":"2009","journal-title":"J Neural Transm"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jneuroim.2008.06.018","article-title":"Suppression of neuroinflammation and immunomodulation by the acetylcholinesterase inhibitor rivastigmine.","volume":"203","author":"E Nizri","year":"2008","journal-title":"J Neuroimmunol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00259-008-1039-z","article-title":"FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's disease.","volume":"36","author":"L Mosconi","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1196\/annals.1427.007","article-title":"Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease.","volume":"1147","author":"L Mosconi","year":"2008","journal-title":"Ann N Y Acad Sci"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0021954","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T06:31:31Z","timestamp":1560407491000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0021954"}},"subtitle":[],"editor":[{"given":"Mark P.","family":"Mattson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,7,22]]},"references-count":65,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2011,7,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0021954","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,22]]}}}